[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
2019-06-18
240
North America
North America OTC Consumer Health Product Market
Market Overview
There is a face-level deceptive similarity between the fabric of Fast Moving Consumer Goods (FMCG) marketing and Over-The-Counter products (OTC) marketing in terms of bonding, impulse buying, consumer research, exposure and directly selling the medicine. OTC drugs are considered by regulators to be safe for self-diagnosis and self-medication. In the United States, there are an estimated 100,000 OTC drug products marketed and sold in a variety of outlets, such as pharmacies and convenience stores. US is one of the world’s most supportive domestic environment for commercialization of pharmaceuticals with minimal market barriers and intellectual property system. Canada is one of the largest exporters of the pharmaceuticals worldwide.
Goldstein Research analyst forecast the OTC consumer health product market size is set to reach USD 49 billion by 2025, at a CAGR of 2.76% over the forecast years. With changing demographics in US & Canada, brand owners will continue to focus on launching solutions that address ageing-related symptoms and expand their portfolio of vitamins and dietary supplements to help prevent chronic illnesses is expected to build sales growth upon key consumer trends over the forecast period.
Intended Audience
Covered In This North America OTC Consumer Health Product Market Report
The report covers the present ground scenario and the future growth prospects of the OTC Consumer Health Product market for 2017-2025 along with the data of end user medical facilities worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The OTC consumer health product market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
North America OTC Consumer Health Product Market Segmentation
By Product Type
By Distribution Channel
Based on Geography
Based on product type, cough cold & allergy remedies segment lead the OTC consumer health products and accounted for the market share of 35% in 2017 due to increasing awareness among the population regarding the potential benefits of using the OTC drugs. Analgesics are the second largest OTC consumer health product market followed by sleep aids and emergency contraception. Nutrition, oral healthcare and digestive remedies are the fastest growing segments owing to widespread outreach of social media and rowing inclination from the pharmaceutical industries to convert their products from Rx to OTC category.
North America OTC Consumer Health Product Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the North America OTC Consumer Health Product Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. North America OTC Consumer Health Product Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.
Our North America OTC Consumer Health Product Market report comprises of the following companies as the key players: Sun Pharmaceuticals Ltd., Abbott Laboratories, GlaxosmithKline plc, Pfizer, Inc., Johnson & Johnson, Piramal Enterprises Ltd., Ipsen, Sanofi S.A., Bayer AG, American Health, Boehringer Ingelheim, Novartis, PGT healthcare, Takeda and Glenmark Pharmaceuticals Ltd.
According to our North America market study on the basis of extensive primary and secondary research: “One trend is the push to switch drugs from prescription to OTC or non-prescription drugs which continues to bring new market expansion opportunities for firms, which is valid in the therapeutic areas of respiratory and digestive health and esomeprazole.”
According to the report, major driving factor is the personalization of consumer health that leads to formidable shift toward lifestyle and wellness programs supported by a holistic approach to self-care. More than 60% of consumers are now always on and readily addressable yet the healthcare industry is just starting to use mobile and social channels as effective engagement channels. In 2015, 32% of American used a mobile app for medical, health, or fitness information, and when people move to mobile they expect real-time reactions.
Further, the report states the biggest challenge is the adverse effects of supplements taken without any physician’s guidance can send the person to the emergency department. Weight-loss products accounted for one quarter of all single-product ED visits and disproportionately affected women, while men were more likely to experience adverse effects from products advertised for sexual enhancement and body building. Energy-boosting products made up another 10% of these visits.
Based on geography, North America held the largest OTC consumer health products and U.S. continues to dominate the OTC consumer health products market representing 30% of the overall industry at USD 38.9 billion in 2017. In Canada, 75% of the adults use OTC medicine as the first response to minor health ailments and that nearly 60% of the parents give their children OTC medicine to treat an immediate medical symptom. Following the USA, Canada is the second biggest market in North America.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
For a full detailed overview, send us the sample request.
Key questions answered in this OTC Consumer Health Product Market Report
We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity , Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region with Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User & by Region with Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024
Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024